🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Endometrial Cancer Stage I

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer NCT07643012NA1 site📍 New Brunswick Rutgers, The State University of New Jersey · Tests: MR-guided adaptive pelvic intensity-modulated radiation therapy (IMRT) Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer NCT05647109n/a1 site📍 Beijing Peking University People's Hospital · Tests: No intervention A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer NCT04845828NA1 site📍 Seoul Asan Medical Center · Tests: Sentinel lymph node mapping, Routine lymph node dissection Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site📍 Beijing Peking University People's Hospital · Tests: Indication-extended Fertility-sparing Therapy MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide Endometrial Cancer Lymphadenectomy Trial NCT03438474NA61 sites📍 Aalen📍 Amberg📍 Ansbach Philipps University Marburg · Tests: Standard surgical procedure for endometrial cancer, systematic lymphadenectomy (LNE) Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers NCT06800612n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Oncologic drugs administered for treatment of breast cancer, Oncologic drug administered for treatment of gynecologic c… CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site📍 Shanghai TJ Biopharma Co., Ltd. · Tests: TJ037130 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer NCT06040970Phase 1, Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Sacituzumab, Cisplatin Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer NCT06468215NA1 site📍 Beijing Peking University People's Hospital · Tests: Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d. Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia NCT04839614NA2 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Aurora Volastra Therapeutics, Inc. · Tests: VLS-1488 Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors NCT05797168Phase 1, Phase 260 sites📍 Duarte📍 Irvine📍 La Jolla AstraZeneca · Tests: Torvutatug samrotecan, Saruparib, Bevacizumab, Carboplatin, Palacaparib Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia NCT06102863Phase 21 site📍 Beijing Peking University People's Hospital · Tests: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Study of Sofe-M in Participants With Selected Advanced Solid Tumors NCT06400472Phase 125 sites📍 Scottsdale📍 La Jolla📍 Atlanta Eli Lilly and Company · Tests: Sofe-M, bevacizumab, carboplatin, Itraconazole, pembrolizumab Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies NCT06552598Phase 11 site📍 Wuhan Tongji Hospital · Tests: KD01(the recombinant oncolytic adenovirus) Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors NCT07444814Phase 112 sites📍 Little Rock📍 Los Angeles📍 Peoria Whitehawk Therapeutics, Inc. · Tests: HWK-007 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989 Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers NCT03968406Phase 12 sites📍 Baltimore📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Radiation Therapy, Talazoparib Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer NCT03422198Phase 35 sites📍 Palo Alto📍 Maywood📍 Houston University of Utah · Tests: Vaginal Cuff Brachytherapy, Short course vaginal cuff brachytherapy Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy PROfiling Based Endometrial Cancer Adjuvant Therapy NCT05179447NA10 sites📍 Wuhan📍 Jinan📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer NCT05819892Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Paclitaxel, Carboplatin, Dostarlimab, Cisplatin Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue NCT07040657NA2 sites📍 Ankara📍 Izmir Dokuz Eylul University · Tests: Sentinel Lymph Node Detection/Cervical Methylene Blue Injection European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III NCT04504006n/a1 site📍 Essen Dr. Paul Buderath · Tests: Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy